- Home
- BGR vs TKNO Comparison
BGR vs TKNO Comparison
Compare BGR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGR
- TKNO
- Stock Information
- Founded
- BGR 2004
- TKNO 1996
- Country
- BGR United States
- TKNO United States
- Employees
- BGR N/A
- TKNO N/A
- Industry
- BGR Trusts Except Educational Religious and Charitable
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- BGR Finance
- TKNO Health Care
- Exchange
- BGR Nasdaq
- TKNO Nasdaq
- Market Cap
- BGR 350.6M
- TKNO 256.9M
- IPO Year
- BGR N/A
- TKNO 2021
- Fundamental
- Price
- BGR $13.59
- TKNO $4.35
- Analyst Decision
- BGR
- TKNO
- Analyst Count
- BGR 0
- TKNO 0
- Target Price
- BGR N/A
- TKNO N/A
- AVG Volume (30 Days)
- BGR 73.3K
- TKNO 224.0K
- Earning Date
- BGR 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- BGR 6.02%
- TKNO N/A
- EPS Growth
- BGR N/A
- TKNO N/A
- EPS
- BGR 0.69
- TKNO N/A
- Revenue
- BGR N/A
- TKNO $38,923,000.00
- Revenue This Year
- BGR N/A
- TKNO $9.52
- Revenue Next Year
- BGR N/A
- TKNO $15.20
- P/E Ratio
- BGR $18.97
- TKNO N/A
- Revenue Growth
- BGR N/A
- TKNO 11.40
- 52 Week Low
- BGR $11.38
- TKNO $4.00
- 52 Week High
- BGR $13.37
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- BGR 63.47
- TKNO 43.35
- Support Level
- BGR $13.18
- TKNO $4.22
- Resistance Level
- BGR $13.31
- TKNO $4.94
- Average True Range (ATR)
- BGR 0.14
- TKNO 0.29
- MACD
- BGR 0.03
- TKNO -0.00
- Stochastic Oscillator
- BGR 82.10
- TKNO 16.75
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.